Shares of Minneapolis-based biotech startup Foxo Technologies Inc. began trading on the New York Stock Exchange less than a year ago. Now, the company is already in danger of being removed from the ...

MINNEAPOLIS--(BUSINESS WIRE)--FOXO Technologies Inc. (NYSEAM: FOXO) (“FOXO” or the “Company”), a leader in commercializing epigenetic biomarkers of health and aging in life insurance, today reported ...

Minneapolis-based Foxo Technologies made its stock market debut last September with a mission to reinvent the life insurance industry. Now, it's teetering on insolvency and shrouded in questions. In a ...

MINNEAPOLIS--(BUSINESS WIRE)--FOXO Technologies Inc.™ (NYSEAM: FOXO), a technology platform company whose products and services seek to address long-standing, core problems within the life insurance ...

WEST PALM BEACH, FLORIDA, July 17, 2025 (GLOBE NEWSWIRE) -- FOXO Technologies Inc. (NYSE American: FOXO) (“FOXO” or the “Company”), today announced that its Board of Directors has approved a 1 for ...

FOXO Technologies Inc. has provided a shareholder update from its newly appointed CEO, Seamus Lagan, reflecting on recent achievements and outlining future plans. Following a significant change in ...

WEST PALM BEACH, FL, Sept. 11, 2025 (GLOBE NEWSWIRE) -- FOXO Technologies Inc. (OTC: FOXO) (the "Company”), announces that it has signed a stock purchase agreement to acquire Vector Biosource Inc.

FOXO Technologies announces a 1-for-1.99 reverse stock split effective July 27, 2025, to maintain NYSE listing compliance. FOXO Technologies Inc. announced a 1-for-1.99 reverse stock split of its ...